Ichnos Glenmark Innovation, AbbVie ink pact for investigational cancer drug Ruchika Sharma11 July 2025 2:54 PM ISTNew York: AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), have announced an...
Alembic Pharma bags USFDA nod for cancer injection Doxorubicin Hydrochloride Liposome Ruchika Sharma1 July 2025 11:38 AM ISTVadodara: Pharmaceutical firm, Alembic Pharmaceuticals Limited, has announced that the company has received final approval from the US...
USFDA approves label updates for Bristol Myers Squibb 2 CAR T cell therapies Ruchika Sharma29 Jun 2025 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved label updates for both of its CAR T...
USFDA lifts Risk Evaluation and Mitigation Strategies for CAR T cell therapies Ruchika Sharma28 Jun 2025 12:59 PM ISTThe U.S. Food and Drug Administration (USFDA) has announced that it has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for currently...
Sanofi Sarclisa recommended for EU approval by CHMP for transplant-eligible newly diagnosed multiple myeloma Ruchika Sharma23 Jun 2025 11:30 AM ISTParis: Sanofi has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...
Full dose escalation data show favorable safety profile of ISB 2001 for Multiple Myeloma: Ichnos Glenmark Innovation Ruchika Sharma3 Jun 2025 5:47 PM ISTNew York: Ichnos Glenmark Innovation (IGI), a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics...
GSK Blenrep combos receive positive EMA Committee opinion in relapsed/refractory multiple myeloma Ruchika Sharma25 May 2025 1:30 PM ISTGSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of...
GSK Blenrep combos win approval in Japan for multiple myeloma Ruchika Sharma20 May 2025 1:45 PM ISTGSK plc has received approval for Blenrep combinations from Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of adults with...
GSK Blenrep combinations approved by UK MHRA in relapsed/refractory multiple myeloma Ruchika Sharma20 April 2025 10:00 AM ISTGSK plc has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Blenrep. In the UK, Blenrep is...
JnJ gets European Commission nod for subcutaneous Darzalex-based quadruplet regimen for newly diagnosed multiple myeloma Ruchika Sharma11 April 2025 10:30 AM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has received approval from the European Commission (EC) for an...
Shilpa Medicare marketing partner Amneal Pharma unveils multiple myeloma treatment Boruzu Ruchika Sharma4 April 2025 12:30 PM ISTKarnataka: Shilpa Medicare has announced that the Company's marketing partner, Amneal Pharmaceuticals, has launched BORUZU, (Bortezomib...
New-onset type 2 diabetes linked to some but not all obesity-related cancers, reveals research Dr. Kamal Kant Kohli27 March 2025 8:00 AM ISTNew research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that a new diagnosis of type 2...
